This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Astellas Pharma Gmbh. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Akiyoshi Ohtake: Innovator in Pharmaceutical Composition
Introduction
Akiyoshi Ohtake is a notable inventor based in Chuo-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of overactive bladder. His innovative work has led to the development of a unique pharmaceutical composition that addresses various symptoms associated with this condition.
Latest Patents
Akiyoshi Ohtake holds a patent for a pharmaceutical composition aimed at treating overactive bladder. The patent includes active ingredients such as (R)-2-(2-aminothiazol-4-yl)-4'-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl}acetanilide and (3R)-quinuclidin-3-yl (1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate. This composition is particularly effective in improving symptoms like urinary urgency, pollakiuria, and urinary incontinence.
Career Highlights
Akiyoshi Ohtake is associated with Astellas Pharma GmbH, where he continues to contribute to pharmaceutical innovations. His work has been instrumental in advancing treatments that enhance the quality of life for patients suffering from overactive bladder.
Collaborations
Akiyoshi Ohtake collaborates with Masashi Ukai, a fellow professional in the pharmaceutical field. Their partnership exemplifies the importance of teamwork in driving innovation and developing effective treatments.
Conclusion
Akiyoshi Ohtake's contributions to pharmaceutical science, particularly in the treatment of overactive bladder, highlight his role as an influential inventor. His patent reflects a commitment to improving patient care through innovative solutions.